IDEAYA Biosciences (NASDAQ: IDYA) reported Q3 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $8.04 million versus the consensus estimate of $8.14 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.